Citro Pharma Private Limited
Indian Pharmaceutical Exporter ยท Biologics & Immunotherapy Specialist ยท $8.8K Total Trade ยท DGFT Verified
Citro Pharma Private Limited is an Indian pharmaceutical exporter with a total trade value of $8.8K across 2 products in 2 therapeutic categories. Based on 7 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Etanercept ($6.0K), Axitinib ($2.8K), .
Citro Pharma Private Limited โ Export Portfolio & Destination Treemap

Who is Citro Pharma Private Limited? โ Company Overview & Market Position
Citro Pharma Private Limited, incorporated on October 14, 2016, is a private pharmaceutical company based in Bangalore, Karnataka, India. The company is registered under the Corporate Identification Number (CIN) U24230KA2016PTC097166. Its authorized and paid-up capital stands at โน100,000 each. The registered office is located at No. 2/A, 4th Main Shampura, K G Halli, Bangalore, Karnataka, 560045.
Citro Pharma specializes in the manufacturing and export of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. The company's export activities are primarily focused on biologics and immunotherapy products, with a notable presence in the advanced oncology therapeutic category. In the fiscal year 2022, Citro Pharma reported a total export value of $9,000 USD, encompassing seven shipments across two therapeutic categories. The top five exported products include Etanercept and Axitinib, with Etanercept accounting for $6,000 USD and Axitinib for $3,000 USD. The company's portfolio is highly concentrated, with the top five products comprising 100% of its export value.